Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2026)

Krystal Biotech has disclosed Exchange Rate Effect across 5 years of filings, most recently posting -$1.3 million for Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at -$1.3 million, down 878.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 156.54% YoY), and the FY2025 annual result was $286000.0, up 162.45% from the prior year.
• Exchange Rate Effect came in at -$1.3 million for Q1 2026 at Krystal Biotech, down from -$637000.0 in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q2 2025 to a low of -$1.3 million in Q1 2026.
• The 5-year median for Exchange Rate Effect is -$38500.0 (2022), against an average of -$121428.6.
• Peak annual rise in Exchange Rate Effect reached 2283.33% in 2024, while the deepest fall reached 4312.5% in 2024.
• Krystal Biotech's Exchange Rate Effect stood at -$41000.0 in 2022, then plunged by 241.46% to -$140000.0 in 2023, then sank by 324.29% to -$594000.0 in 2024, then slipped by 7.24% to -$637000.0 in 2025, then sank by 108.95% to -$1.3 million in 2026.
• The last three Exchange Rate Effect figures came in at -$1.3 million (Q1 2026), -$637000.0 (Q4 2025), and -$307000.0 (Q3 2025), per Business Quant data.